Program Goals

Click here to register for this event

In its various forms and presentations, cardiovascular disease (CVD) is the number one cause of death worldwide. Although numerically less important, nevertheless renal disease, consisting of renal impairment leading ultimately to renal failure, is also an important cause of morbidity and mortality. What has been largely underappreciated are the ways that these two disease processes interact, both biologically and physiologically, as well as in the disease process and progression of a patient who presents with either, often as a prelude to having both. Since increasing clinical trial evidence has found that in addition to the diseases complementing each other, in like manner the best evidence-based treatment for CVD is also effective in CKD patients, and a greater understanding of this by physicians would be of great benefit to patients.

Target Audience

The educational design of this activity addresses the needs of Internal Medicine Providers, Cardiologists, and Nephrologists involved in the treatment of patients with Cardiovascular disease, Dyslipidemia, Renal Impairment, and Chronic Kidney Disease.

Educational Objectives

Upon completion of this activity, participants should be able to:

  1. Review the demographics, epidemiology and inter-relationships of chronic kidney disease, cardiovascular disease and dyslipidemia.
  2. Recognize the risks of chronic kidney disease progression and cardiovascular disease in patients who are at risk for, or already presenting with, these comorbid conditions.
  3. Describe the challenges of treating concomitant chronic kidney disease and dyslipidemia patients, based on limited available evidence-based medical approaches relative to the general population.

Faculty

 

Bakris.png Joseph Vassalotti, MD, FASN
Chief Medical Officer
National Kidney Foundation
Associate Clinical Professor of Medicine
Mount Sinai School of Medicine
New York, NY
Block.png

George Bakris, MD, FAHA, FASN
Professor of Medicine
Hypertensive Diseases Unit, Department of Medicine
The University of Chicago-Pritzker School of Medicine
Chicago, IL

Jones.png

Peter Jones, MD
Associate Professor of Medicine
Atherosclerosis and Lipid Research
Baylor College of Medicine
Houston, TX

Vassalotti.png

Michael J. Bloch, MD
Associate Professor
Department of Internal Medicine
University of Nevada School of Medicine
Reno, NV

Educational Activity Agenda

Multi-specialty Discussion of Treating Patients with Cardiovascular Risk and Chronic Kidney Disease

  • Faculty Introduction (1 minute)
  • Faculty Presentation (110 minutes)
  • Post Test, Evaluation, and Credit Application (9 minutes)

Release and Expiration Dates

Enduring Archive CME Release Date: November 14, 2011
Enduring Archive CME Expiration Date: November 14, 2012

Disclosure of Conflicts of Interests

Global Education Group requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Faculty Disclosures

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

NAME TYPE COMMERCIAL SUPPORTERS
Joseph Vassalotti, MD,FASN Grant/Research Support Boehringer-Ingelheim
Honoraria Gore Creative Technologies
George Bakris, MD, FAHA, FASN Consultant Relapysa, CVRx
Grant/Research Support Forest, Novartis
Speakers Bureau Takeda, Novartis
Peter Jones, MD Consultant Genentech/Roche, Merck, Abbott, Atherotech
Speakers Bureau Merck
Michael J. Bloch, MD Consultant AstraZeneca, Takeda
Honoraria (Spouse) Biogen, Pfizer
Speakers Bureau AstraZeneca, Boehringer-Ingelheim, Takeda

Planners and Managers

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

GLOBAL EDUCATION GROUP
PLANNER OR MANAGERFINANCIAL RELATIONSHIP
Jackie Dawson, MSN
Nothing to disclose
Amanda Glazar, PhD
Nothing to disclose

ELSEVIER, INC.
PLANNER OR MANAGERFINANCIAL RELATIONSHIP
Craig Smith
Nothing to disclose
David Good
Nothing to disclose

Physician Accreditation Statement - CME

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the Joint Sponsorship of Global Education Group (Global) and Elsevier, Inc..  Global is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit Designation - CME

Global Education Group designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Global Education Group

For information about the physician accreditation of this activity, please contact Global Education Group at (303) 395-1782, or inquire@globaleducationgroup.com.

How to Obtain CME Credit

Attendees are expected to view all presentations before attempting to take the test and/or complete the activity evaluation. Successful completion will lead to the issuance of a certificate for AMA PRA Category 1 Credits™. To receive credit, the course must be completed between November 14, 2011 and November 14, 2012.

Participation in this activity should be completed in approximately 2.0 hours. Please follow these steps in order to receive CME credit for viewing the webcast:

  • Read all of the CME accreditation information above.
  • View the complete webcast program.
  • Click on the link to apply for CME credits.
  • Complete the online registration (registration is free).
  • Complete the online test and/or evaluation. Participants must receive a test score of at least 75% and answer all evaluation questions to receive a certificate.

After successfully completing the online test and/or evaluation, your application will be immediately processed and you will be given the opportunity to download a personalized CME certificate for participation in this activity. 

Should you have any CME questions regarding this activity, please contact:

Global Education Group
5575 S. Sycamore Street, Suite 200
Littleton, CO 80120
Phone: 303-395-1782
Fax: 303-648-5311
Email: inquire@globaleducationgroup.com
Web: www.globaleducationgroup.com

 

Fee Information

There is no fee for this educational activity.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global Education Group (Global) does not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Policy on Privacy and Confidentiality

Global Education Group protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. Global Education Group and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.

Global Education Group and Elsevier, Inc. maintain physical, electronic and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Medium Used

This program has been made available online.
“Multi-specialty Approaches to Patients with Comorbid Chronic Kidney Disease and Cardiovascular Disease"

System Requirements

To view the this educational activity you will need a web broswer with Javascript and either Flash or HTML5 enabled.  Nearly all modern web browsers will work.

Commercial Support Statement

Merck__Co._Inc.png  This activity is supported by an educational grant from Merck.

Copyright

Copyright © November 14, 2011 - November 14, 2012.   Dane Garvin, Ltd. All Rights Reserved.   Permission for accreditation use granted to Global Education Group and Elsevier, Inc.